Work

A window into new drug development for urologic oncology. Part I: How bench-to-bedside research can result in approval

Year: 2015

Type: editorial

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2014.12.004

Authors: Gabriel P. Haas, Howard I. Scher

Institutions: Loyola University Medical Center, Loyola University Chicago, Loyola Medicine, Astellas Pharma (United States), Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1981968485

Cites:

Cited by:

Related to: 10